Patterns of Failure Following Concurrent Bevacizumab and Hypofractionated Stereotactic Radiotherapy for Recurrent High-grade Glioma

被引：2
|
作者：
Shapiro, L. Q. [1 ]
Karimi, S. [1 ]
Gutin, P. H. [1 ]
Iwamoto, F. M. [2 ]
Zhang, Z. [1 ]
Lassman, A. B. [1 ]
Abrey, L. E. [1 ]
Beal, K. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] NCI, NIH, Bethesda, MD 20892 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 75卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2009.07.301
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S125 / S125
页数：1
相关论文
共 50 条
  • [1] Patterns of Failure After Concurrent Bevacizumab and Hypofractionated Stereotactic Radiation Therapy for Recurrent High-Grade Glioma
    Shapiro, Lauren Q.
    Beal, Kathryn
    Goenka, Anuj
    Karimi, Sasan
    Iwamoto, Fabio M.
    Yamada, Yoshiya
    Zhang, Zhigang
    Lassman, Andrew B.
    Abrey, Lauren E.
    Gutin, Philip H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (03): : 636 - 642
  • [2] Patterns of Failure in Patients With Recurrent High-Grade Glioma Treated With Hypofractionated Stereotactic Re-rradiation, Pembrolizumab, and Bevacizumab
    Padmanabhan, R.
    Zhang, G. G.
    Oliver, D. E.
    Graham, J.
    Grass, D.
    Sahebjam, S.
    Yu, H. H. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E596 - E597
  • [3] Patterns of Failure Following Stereotactic Radiosurgery Salvage for Recurrent High-Grade Glioma
    Gonzalez, B.
    Esquenazi, Y.
    Dono, A.
    Riascos, R.
    Zhu, J. J.
    Hsu, S.
    Tandon, N.
    Blanco, A. I.
    Amsbaugh, M. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E71 - E71
  • [4] Hypofractionated Stereotactic Reirradiation for Recurrent High-grade Glioma
    Hynkova, L.
    Slampa, P.
    Kazda, T.
    Garcic, J.
    Vrzal, M.
    Fadrus, P.
    Belanova, R.
    Sikova, I.
    Dvorak, D.
    Dolezelova, H.
    Pospisil, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S617 - S617
  • [5] Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
    Arpa, Donatella
    Parisi, Elisabetta
    Ghigi, Giulia
    Cortesi, Annalisa
    Longobardi, Pasquale
    Cenni, Patrizia
    Pieri, Martina
    Tontini, Luca
    Neri, Elisa
    Micheletti, Simona
    Ghetti, Francesca
    Monti, Manuela
    Foca, Flavia
    Tesei, Anna
    Arienti, Chiara
    Sarnelli, Anna
    Martinelli, Giovanni
    Romeo, Antonio
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Hypofractionated Radiation Therapy With Concurrent Temozolamide for Recurrent High-Grade Glioma
    Garg, S.
    Palmer, J. D.
    Kim, H.
    Williams, N. L.
    Bhamidipati, D.
    Skowronski, J.
    Glass, J.
    Werner-Wasik, M.
    Kim, L.
    Shi, W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E95 - E95
  • [7] Hypofractionated stereotactic radiotherapy as a salvage therapy for recurrent high-grade gliomas
    Reynaud, T.
    Vulquin, N.
    Farah, W.
    Thibouw, D.
    Crehange, G.
    Bertaut, A.
    Truc, G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S669 - S669
  • [8] Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge
    Navarria, Pierina
    Ascolese, Anna Maria
    Tomatis, Stefano
    Reggiori, Giacomo
    Clerici, Elena
    Villa, Elisa
    Maggi, Giulia
    Bello, Lorenzo
    Pessina, Federico
    Cozzi, Luca
    Scorsetti, Marta
    [J]. CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 37 - 44
  • [9] Salvage Stereotactic Radiosurgery for Recurrent High-Grade Glioma with Prior Radiotherapy
    Costantini, Mary
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 189 - 189
  • [10] HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY (HSR) IN RECURRENT HIGH GRADE GLIOMA: A SAFE AND EFFECTIVE APPROACH
    Ascolese, A.
    Pessina, F.
    Navarria, P.
    Tomatis, S.
    Mancosu, P.
    Clerici, E.
    Bello, L.
    Lobefalo, F.
    Grimaldi, M.
    Scorsetti, M.
    [J]. NEURO-ONCOLOGY, 2014, 16
12345